Dataset Information


Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

ABSTRACT: Enhanced RAS signaling and decreased androgen dependence of prostate cancer cells accompany poor clinical outcomes. Elevated autocrine fibroblast growth factors 2 (FGF-2) signaling promotes prostate cancer cell growth and survival. Expression of lysyl oxidase (LOX) inhibits RAS transforming activity. LOX is secreted as 50 kDa pro-LOX protein and then undergoes extracellular proteolytic processing to form approximately 30 kDa LOX enzyme and approximately 18 kDa propeptide (LOX-PP). We have previously shown that LOX-PP inhibits breast cancer cell transformation and tumor formation, but mechanisms of action of LOX-PP have not been fully elucidated. Here we report that LOX expression is reduced in prostate cancer cell lines and that recombinant LOX-PP protein inhibits serum-stimulated DNA synthesis and MEK/ERK and PI3K/AKT pathways in DU 145 and PC-3 androgen-independent cell lines. In DU 145 cells, treatment with a pharmacologic FGF-receptor inhibitor or a neutralizing anti-FGFR1 antibody mimicked LOX-PP inhibition of serum-stimulated DNA synthesis. FGF-2-stimulated DNA synthesis, ERK1/2, AKT and FRS2alpha activation were found all to be inhibited by LOX-PP in DU 145 cells. LOX-PP reduced specific binding of FGF-2 to DU 145 cells, suggesting that LOX-PP targets FGF signaling at the receptor. Interestingly, PC-3 cells did not respond to FGF-2, consistent with previous reports. We conclude that LOX-PP inhibits proliferation of DU 145 cells by interfering with FGFR(s) binding and signaling, and that LOX-PP has other mechanisms of action in PC-3 cells.

SUBMITTER: Palamakumbura AH 

PROVIDER: S-EPMC2753565 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5119235 | BioStudies
2011-01-01 | S-EPMC3230309 | BioStudies
2017-01-01 | S-EPMC5399964 | BioStudies
| S-EPMC7495929 | BioStudies
| S-EPMC5358703 | BioStudies
2008-01-01 | S-EPMC2259456 | BioStudies
2015-01-01 | S-EPMC4694976 | BioStudies
1000-01-01 | S-EPMC3320557 | BioStudies
2015-01-01 | S-EPMC4521694 | BioStudies
2020-01-01 | S-EPMC7359077 | BioStudies